BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 19443254)

  • 1. [Intravenous immunoglobulins in autoimmune and inflammatory disorders: beyond a simple substitution].
    Galeotti C; Maddur MS; Kazatchkine MD; Mouthon L; Kaveri SV
    Transfus Clin Biol; 2009 May; 16(2):75-9. PubMed ID: 19443254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of intravenous polyclonal immunoglobulins in autoimmune and inflammatory disorders].
    Graff-Dubois S; Sibéril S; Elluru S; Negi VS; Delignat S; Mouthon L; Lacroix-Desmazes S; Kazatchkine MD; Bayary J; Kaveri SV
    Transfus Clin Biol; 2007 May; 14(1):63-8. PubMed ID: 17498995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immunoglobulin in autoimmune and inflammatory diseases: more than mere transfer of antibodies.
    Sibéril S; Elluru S; Negi VS; Ephrem A; Misra N; Delignat S; Bayary J; Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV
    Transfus Apher Sci; 2007 Aug; 37(1):103-7. PubMed ID: 17765663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders.
    Ballow M
    J Allergy Clin Immunol; 2011 Feb; 127(2):315-23; quiz 324-5. PubMed ID: 21185071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulation of autoimmune and inflammatory diseases with intravenous immunoglobulin.
    Ephrem A; Misra N; Hassan G; Dasgupta S; Delignat S; Duong Van Huyen JP; Chamat S; Prost F; Lacroix-Desmazes S; Kavery SV; Kazatchkine MD
    Clin Exp Med; 2005 Dec; 5(4):135-40. PubMed ID: 16362793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic intravenous immunoglobulins.
    Lemieux R; Bazin R; Néron S
    Mol Immunol; 2005 May; 42(7):839-48. PubMed ID: 15829272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanisms of action of intravenous immunoglobulins in the treatment of autoimmune diseases].
    Mouthon L; Hurez V; Kazatchkine M
    Ann Med Interne (Paris); 1993; 144(8):506-13. PubMed ID: 8179238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immunoglobulins in autoimmune and inflammatory diseases: a mechanistic perspective.
    Sibéril S; Elluru S; Graff-Dubois S; Negi VS; Delignat S; Mouthon L; Lacroix-Desmazes S; Kazatchkine MD; Bayry J; Kaveri SV
    Ann N Y Acad Sci; 2007 Sep; 1110():497-506. PubMed ID: 17911465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of action of intravenous immunoglobulins.
    Baerenwaldt A; Biburger M; Nimmerjahn F
    Expert Rev Clin Immunol; 2010 May; 6(3):425-34. PubMed ID: 20441428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of natural antibodies in immune homeostasis: IVIg perspective.
    Vani J; Elluru S; Negi VS; Lacroix-Desmazes S; Kazatchkine MD; Bayry J; Kaveri SV
    Autoimmun Rev; 2008 Jun; 7(6):440-4. PubMed ID: 18558359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases.
    Bayry J; Thirion M; Misra N; Thorenoor N; Delignat S; Lacroix-Desmazes S; Bellon B; Kaveri S; Kazatchkine MD
    Neurol Sci; 2003 Oct; 24 Suppl 4():S217-21. PubMed ID: 14598046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of intravenous immunoglobulin therapy in autoimmune and inflammatory disorders.
    Emmi L; Chiarini F
    Neurol Sci; 2002 Apr; 23 Suppl 1():S1-8. PubMed ID: 12032582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanisms of action of intravenous immunoglobulins].
    Kaveri SV
    Bull Acad Natl Med; 2012 Jan; 196(1):39-47; discussion 47-8. PubMed ID: 23259331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous immunoglobulins induce potentially synergistic immunomodulations in autoimmune disorders.
    Imbach P; Lazarus AH; Kühne T
    Vox Sang; 2010 Apr; 98(3 Pt 2):385-94. PubMed ID: 19821958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of action of intravenous immunoglobulin (IVIG).
    Kazatchkine MD; Bellon B; Kaveri SV
    Mult Scler; 2000 Oct; 6 Suppl 2():S24-6; discussion S33. PubMed ID: 11188775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune modulating effects of intravenous immunoglobulin (IVIg) in autoimmune diseases.
    Mouthon L; Kaveri S; Kazatchkine M
    Transfus Sci; 1994 Dec; 15(4):393-408. PubMed ID: 10155557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases.
    Bayry J; Misra N; Latry V; Prost F; Delignat S; Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV
    Transfus Clin Biol; 2003 Jun; 10(3):165-9. PubMed ID: 12798851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B cells are resistant to immunomodulation by 'IVIg-educated' dendritic cells.
    Maddur MS; Hegde P; Sharma M; Kaveri SV; Bayry J
    Autoimmun Rev; 2011 Dec; 11(2):154-6. PubMed ID: 21864723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanisms of immunoglobulins activity].
    Kowalczyk D
    Pol Merkur Lekarski; 2011 Jun; 30(180):397-9. PubMed ID: 21751546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunosuppressive mechanisms for immunoglobulin function].
    Miller A; Jedrzejczak WW
    Postepy Hig Med Dosw; 2000; 54(4):423-44. PubMed ID: 11016265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.